0113 206 7917
Summary: I lead the Patient Centred Outcomes Group in LICAP.
Location: Bexley Wing
Teaching Commitments: Teaching Undergraduate Medical Students and Junior Doctors within Oncology
Recent research, funded by National Institute for Health Research in UK, includes the development of a web-based electronic system for collecting patient-reported data on toxicity and adverse events during cancer treatment, integrating this with electronic patient records and generating alerts for clinicians.
Prof Velikova leads the quality of life sub-studies of large national and international research trials in breast cancer. She is involved in the implementation in NHS, locally of holistic needs assessment for cancer patients (NICE supportive & palliative care guidelines) and nationally contributes to the National Cancer Survivorship Initiative.
Professor Velikova is past chair the British Psychosocial Oncology Society (BPOS) and the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group. She is president elect of the International Society for Quality of Life Research.
Professor Velikova graduated from the Medical Institute, Varna, Bulgaria in 1986. She obtained a specialty degree in Internal Medicine in Bulgaria in 1994. Then she moved to UK and completed specialist training in Medical Oncology in 2001. She obtained a PhD from the University of Leeds 2001 for a research degree project Quality of life measurement in daily oncology practice.
She is a Consultant in Medical Oncology and a Professor at the University of Leeds. Her clinical work focuses on systemic treatment of breast cancer patients with early and advanced disease. Professor Velikova leads a research group to study the implementation of routine measurement of patient-reported outcomes and quality of life in oncology practice (http://www.pogweb.org/). More recently, with development funding from the National Institute for Health Research, she researches the use of online patient self-reporting of adverse events during and after treatment with chemotherapy and radiotherapy. The self-reports are being developed to be integrated with the Electronic Patient Records to support immediate patient care.
Prof Velikova leads the quality of life sub-studies of national and international research trials in breast cancer, including TACT2 and SUPREMO. She supports the local implementation of holistic needs assessment of cancer patients, based on self-reporting of distress (NICE supportive & palliative care guidelines). Nationally she contributes to the National Cancer Survivorship Initiative.
Professor Velikova is the president-elect of the International Society for Quality of Life Research (ISOQOL). In the past she has chaired the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group and the British Psychosocial Oncology Society (BPOS).